Manufacturer record

Orchid Medlife Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Orchid Medlife Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2024 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Orchid Medlife Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2024 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2024
4
Products affected
Dissolution
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2024 · 12025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Zinc Acetate Dispersable Tablets 20 mg TD250606Mfg 2025-04 · Exp 2027-03 The sample is not of standard quality for the reason stated under "Description" of the tabletsDescription Office of Drugs Controller, MeghalayaState lab Feb 2026
Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP TA250025Mfg 2025-01 · Exp 2026-12 Dissolution (Montelukast Sodium)Dissolution SDTL, GuwahatiState lab Dec 2025
Ibuprofen Tablets IP 400mg TF240782Mfg 2024-06 · Exp 2026-08 Sample does not conform to claim as per I.P. 2022 w.r.t. Dissolution of Ibuprofen.Dissolution DTL BaddiState lab Apr 2025
Rabeprazole Sodium Gastro-Resistant Tablets IP 20 mg (Rben-20 Tablets) TJ231109Mfg 2023-10 · Exp 2025-09 Dissolution (Buffer stage)Dissolution RDTL ChandigarhState lab Mar 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.